Position in PFE
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$3,747,714
-$516,964 QoQ
Shares Held
155,636
+2.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
#719
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argyle Capital Management, LLC holds $43,679,401 across 8 Drug Manufacturers - General names. PFE ranks #6 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,767 | $12,914,263 | |
| 2 | MRK |
Merck & Co., Inc.
|
62,540 | $8,036,390 | |
| 3 | AMGN |
Amgen Inc
|
19,501 | $7,061,702 | |
| 4 | JNJ |
Johnson & Johnson
|
25,649 | $6,514,076 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
72,282 | $4,164,888 | |
| 6 | PFE |
Pfizer Inc
This page
|
155,636 | $3,747,714 | |
| 7 | ABBV |
AbbVie Inc.
|
3,450 | $868,158 | |
| 8 | NVS |
Novartis AG
|
2,375 | $372,210 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,747,714 | 155,636 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $4,264,678 | 151,876 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $3,633,557 | 145,926 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $3,514,354 | 137,926 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $3,350,113 | 138,206 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $3,514,810 | 138,706 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $3,576,403 | 134,806 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,689,444 | 127,486 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $3,709,336 | 132,571 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $3,464,476 | 124,846 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $3,376,577 | 117,283 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $4,550,924 | 137,200 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $5,032,496 | 137,200 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $5,765,325 | 141,307 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $7,240,570 | 141,307 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $6,198,691 | 141,652 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $7,416,328 | 141,452 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $7,387,889 | 142,706 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $8,810,082 | 149,197 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $6,520,186 | 151,597 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $5,948,286 | 151,897 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $5,503,228 | 151,897 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $5,591,328 | 151,897 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $5,574,614 | 151,897 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $5,019,357 | 153,497 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $5,021,037 | 153,831 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||